WHO issues emergency use listing for COVAXIN Covid-19 jab | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Saturday
June 14, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
SATURDAY, JUNE 14, 2025
WHO issues emergency use listing for COVAXIN Covid-19 jab

Coronavirus chronicle

TBS Report
03 November, 2021, 06:30 pm
Last modified: 03 November, 2021, 07:15 pm

Related News

  • Argentina ratifies WHO withdrawal during US health chief's visit
  • Gaza health system at breaking point as Israeli hostilities intensify, WHO says
  • WHO members adopt global pandemic accord but US absence casts doubts
  • WHO chief says 2 million 'starving' in Gaza
  • World Health Organization looks ahead to life without the US

WHO issues emergency use listing for COVAXIN Covid-19 jab

WHO’s emergency use listing (EUL) procedure assesses the quality, safety and efficacy of Covid-19 vaccines

TBS Report
03 November, 2021, 06:30 pm
Last modified: 03 November, 2021, 07:15 pm
WHO issues emergency use listing for COVAXIN Covid-19 jab

The World Health Organisation (WHO) on Wednesday (3 November) issued an emergency use listing (EUL) for COVAXIN, adding to a growing portfolio of vaccines validated by WHO for the prevention of Covid-19 caused by SARS-CoV-2.

WHO's EUL procedure assesses the quality, safety and efficacy of Covid-19 vaccines and is a prerequisite for COVAX vaccine supply. It also allows countries to expedite their own regulatory approval to import and administer Covid-19 vaccines, said a press release.

COVAXIN is developed by India's Bharat Biotech.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

"This emergency use listing expands the availability of vaccines, the most effective medical tools we have to end the pandemic," said WHO Assistant-Director General for Access to Medicines and Health Products  Dr Mariângela Simão.

 "But we must keep up the pressure to meet the needs of all populations, giving priority to the at-risk groups who are still waiting for their first dose, before we can start declaring victory," she added. 

COVAXIN was assessed under the WHO EUL procedure based on the review of data on quality, safety, efficacy, a risk management plan and programmatic suitability.

The Technical Advisory Group (TAG), convened by WHO and made up of regulatory experts from around the world, has determined that the vaccine meets WHO standards for protection against Covid-19, that the benefit of the vaccine far outweighs risks and the vaccine can be used globally.

The vaccine is formulated from an inactivated SARS-CoV-2 antigen and is presented in single dose vials and multidose vials of 5, 10 and 20 doses.

COVAXIN was also reviewed on 5 October by WHO's Strategic Advisory Group of Experts (SAGE) on immunisation, which formulates vaccine specific policies and recommendations for vaccines' use in populations, the press release added.

The SAGE recommended use of the vaccine in two doses, with a dose interval of four weeks, in all age groups 18 and above. COVAXIN was found to have 78% efficacy against Covid-19 of any severity, 14 or more days after the second dose, and is extremely suitable for low- and middle-income countries due to easy storage requirements.

Available data on vaccination of pregnant women with the vaccine are insufficient to assess vaccine safety or efficacy in pregnancy; studies in pregnant women are planned, including a pregnancy sub-study and a pregnancy registry.

EUL procedure assesses the suitability of novel health products during public health emergencies. The objective is to make medicines, vaccines and diagnostics available as rapidly as possible to address the emergency while adhering to stringent criteria of safety, efficacy and quality. The assessment weighs the threat posed by the emergency as well as the benefit that would accrue from the use of the product against any potential risks.

The assessesment involves a rigorous assessment of late phase II and phase III clinical trial data, as well as substantial additional data on safety, efficacy, quality and a risk management plan. These data are reviewed by independent experts and WHO teams who consider the current body of evidence on the vaccine under consideration, the plans for monitoring its use, and plans for further studies.

As part of the EUL process, the company producing the vaccine must commit to continue to generate data to enable full licensure and WHO prequalification of the vaccine.

The WHO prequalification process will assess additional clinical data generated from vaccine trials and deployment on a rolling basis to ensure the vaccine meets the necessary standards of quality, safety and efficacy for broader availability.

Top News

World Health Organisation (WHO) / COVAXIN / Bharat Biotech Covid-19 vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Benjamin Netanyahu in a video-message on 14 June. Photo: Collected
    Israel will strike 'every site and every target' of Iran, Netanyahu says
  • Police stand at a crime scene as they searched for a suspect posing as a police officer who shot two Democratic state lawmakers and their spouses in their homes, in the Minneapolis suburb of Champlin, Minnesota, U.S. June 14, 2025 in a still image from video. ABC Affiliate KTSP via REUTERS
    Manhunt underway after Minnesota lawmaker, her husband killed in 'politically motivated' attack
  • Burnt out cars and damaged buildings are all that’s left of this street in Ramat Gan Credit: AP
    Iran threatens to strike US, UK, and French bases if they help defend Israel

MOST VIEWED

  • Energy adviser Fouzul Kabir Khan with other government officials during a visit to Sylhet gas field on 13 June 2025. Photo: TBS
    I would disconnect gas supply to every home in Dhaka if I could: Energy adviser
  • Infographic: TBS
    Govt plans incentives for Bangladeshis bringing in foreign investment
  • Tour operator Borsha Islam. Photo: Collected
    ‘Tour Expert’ admin Borsha Islam arrested over Bandarban tourist deaths
  • BNP Acting Chairperson Tarique Rahman and Chief Adviser  Muhammad Yunus meet at Dorchester Hotel in London, UK on 13 June 2025. Photo: CA Press Wing
    National polls possible in 2nd week of February, agree Yunus, Tarique in 'historic' London meeting
  • Infographics: TBS
    220MW solar power plant planned in Feni
  • Rescuers work at the scene of a damaged building in the aftermath of Israeli strikes, in Tehran, Iran, June 13, 2025. Majid Asgaripour/WANA (West Asia News Agency) via REUTERS
    Tehran retaliates with 100 drones after Israel strikes Iran's nuclear facilities, kills military leaders

Related News

  • Argentina ratifies WHO withdrawal during US health chief's visit
  • Gaza health system at breaking point as Israeli hostilities intensify, WHO says
  • WHO members adopt global pandemic accord but US absence casts doubts
  • WHO chief says 2 million 'starving' in Gaza
  • World Health Organization looks ahead to life without the US

Features

Photos: Collected

Kurtis that make a great office wear

1d | Mode
Among pet birds in the country, lovebirds are the most common, and they are also the most numerous in the haat. Photo: Junayet Rashel

Where feathers meet fortune: How a small pigeon stall became Dhaka’s premiere bird market

3d | Panorama
Illustration: Duniya Jahan/ TBS

Forget Katy Perry, here’s Bangladesh’s Ruthba Yasmin shooting for the moon

4d | Features
File photo of Eid holidaymakers returning to the capital from their country homes/Rajib Dhar

Dhaka: The city we never want to return to, but always do

5d | Features

More Videos from TBS

Why Did Israel Use Hellfire Missiles in the Iran Attack?

Why Did Israel Use Hellfire Missiles in the Iran Attack?

30m | Others
Beach Sand Tragedy: Negligence or Natural Disaster?

Beach Sand Tragedy: Negligence or Natural Disaster?

1h | TBS Stories
News of The Day, 14 JUNE 2025

News of The Day, 14 JUNE 2025

2h | TBS News of the day
Major General Hatemi is the new chief of staff of Iran's army

Major General Hatemi is the new chief of staff of Iran's army

3h | TBS World
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net